Research Articles on Tuberculosis from 1940 onwards

Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosispatients.
Antimicrob Agents Chemother. 2010 Aug;54(8):3402-7.
Production and characterization of monoclonal antibody against Mycobacterium tuberculosisRpfB domain.
Hybridoma (Larchmt). 2010 Aug;29(4):327-32.
A concise and convergent synthesis of PA-824.
J Org Chem. 2010 Nov 5;75(21):7479-82.
Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis.
Sci Transl Med. 2019 Nov 13;11(518). pii: eaaw6635.
Nonparametric Population Pharmacokinetic Modeling of Isoniazid in Colombian Patients With Tuberculosis.
Ther Drug Monit. 2019 Dec;41(6):719-725.
Mycobacterium tuberculosis CysA2 is a dual sulfurtransferase with activity against thiosulfate and 3-mercaptopyruvate and interacts with mammalian cells.
Sci Rep. 2019 Nov 14;9(1):16791.
Identification of novel scaffolds targeting Mycobacterium tuberculosis.
J Mol Med (Berl). 2019 Nov;97(11):1601-1613.
The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
Cell Mol Life Sci. 2019 Nov 15.
Characterization of a novel Mycobacterium tuberculosis serine protease (Rv3194c) activity and pathogenicity.
Tuberculosis (Edinb). 2019 Dec;119:101880.
Association between Takayasu arteritis and latent or active Mycobacterium tuberculosis infection: a systematic review.
Clin Rheumatol. 2019 Nov 15.